Figure 6
This illustration shows the viability percentage of HEK293T cells (a) BT549 cells (b) after treatment with TG hydrogel/SF/Fe3O4 nanobiocomposite at days 2 and 3(* = insignificant, P ≥ 0.05).
Figure 6 | Scientific Reports
This illustration shows the viability percentage of HEK293T cells (a) BT549 cells (b) after treatment with TG hydrogel/SF/Fe3O4 nanobiocomposite at days 2 and 3(* = insignificant, P ≥ 0.05).
